GlobeNewswire 2025-08-07 Talisker Receives Assay Results from 1075 Level Lateral Development at the Mustang Mine
GlobeNewswire 2025-07-28 BioPorto attends the Association for Diagnostics & Laboratory Medicine meeting, where NGAL and Acute...
GlobeNewswire 2025-07-24 Talisker Receives Assay Results from 1105 Level Lateral Development at the Mustang Mine
GlobeNewswire 2025-07-22 Fury Reports Encouraging Metallurgical Test Results from the Ninaaskumuwin Lithium Discovery at Elme...
GlobeNewswire 2025-07-13 Panama Announces Emergence as the Next Premier Destination for Luxury Real Estate Investment
TMX Newsfile 2025-07-02 Sale Completion of Non-Core Irish Assets for CAD$ 2.5 million
GlobeNewswire 2025-06-30 The Bouzy Group Announces Westin-Branded Residences Near Panama City, Offering New Investment Opport...
GlobeNewswire 2025-06-26 BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & ...
GlobeNewswire 2025-06-24 BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Re...
GlobeNewswire 2025-06-24 LKQ Corporation and SYNETIQ, an IAA Company Announce Strategic European Joint Venture
GlobeNewswire 2025-06-10 Axsome Therapeutics Announces Availability of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Tr...
GlobeNewswire 2025-06-05 Diginex Limited Signs MOU to Acquire Resulticks for US$2bn, transforming AI and Data Management Capa...
GlobeNewswire 2025-06-04 ROHM Develops Breakthrough AI-Equipped MCU
GlobeNewswire 2025-05-20 EverCommerce Appoints Amy Guggenheim Shenkan to Its Board of Directors
GlobeNewswire 2025-05-15 Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Bu...
GlobeNewswire 2025-05-14 BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Par...
GlobeNewswire 2025-05-07 BioVie to Present Rationale and Design of Phase 2 SUNRISE-PD Clinical Trial at the 30th World Congre...
GlobeNewswire 2025-05-05 BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Maste...
GlobeNewswire 2025-05-05 Regeneration Biomedical to Present Updated Phase 1 Trial Data on Autologous Stem Cell Therapy Inject...
GlobeNewswire 2025-04-22 Zurab Tsereteli, Internationally Acclaimed Artist and Friend of Wolf Popper LLP, Dies at 91
GlobeNewswire 2025-04-16 BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with Fi...
GlobeNewswire 2025-04-15 Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targe...
GlobeNewswire 2025-04-15 Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Ph...
GlobeNewswire 2025-04-01 REPEAT -- Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164...
GlobeNewswire 2025-04-01 Sky Quarry Reports 4th Quarter and Fiscal Year 2024 Financial Results